Optimizing Operations Continue for Legal Marijuana Industry - Company Acquires Option for Cannabis Genetic Catalog for 22 Unique Strains
CORAL SPRINGS, Florida, May 29, 2014 /PRNewswire/ --
Cannabis companies dealing with Legal Medical Marijuana Industry continue to make progress by developing products through advancements, acquisitions and research: OSL Holdings (OTC: OSL), Cannabis Science, Inc. (OTC: CBIS), Easton Pharmaceuticals Inc. (OTC: EAPH), GreenGro Technologies, Inc. (OTC: GRNH) and Vape Holdings, Inc. (OTC: VAPE)
OSL Holdings (OTCQB: OSLH), a growth-stage public company in the business of acquiring and optimizing key aspects of the legal cannabis industry, today announced that it has executed a definitive agreement for an option to acquire the exclusive rights to a genetic catalog of 22 unique cannabis strains including several "clone only" varietals and three exclusive nutrient mixtures, one of which is organic (OMRI listed).
To read the full OSLH press release please go to:http://fnmprofiles.com/profiles-oslh.html
"With the acquisition of these premium genetics and nutrients, OSL continues to build its portfolio of exclusive products and know-how that may be licensed to our partners and clients in the future," said Bob Rothenberg, CEO of OSL Holdings. "We believe that unique, consistent, high-quality products will be a significant market differentiator and competitive advantage, which we will be able to provide to our licensing partners in the form of cutting-edge genetics and nutrients."
Cannabis Science, Inc. (OTC: CBIS) a U.S. Company specializing in the development of cannabis based medicine, is working closely with Mediwiet and its founder, Mr. Wernard Bruining, on the building blocks necessary for the launch of the Clinical Observational Study, as previously announced. MEDIWIET is by far the largest European organization of patients who use medicinal cannabis-based treatments. "Over 3,000 people have contacted Mediwiet and the numbers are growing," stated Mr. Mario Lap, President of European Operations and Director of Cannabis Science B.V. Mediwiet patients, unlike most who receive medicinal cannabis distributed by pharmacies or dispensaries in the Netherlands, only use non-smokable, orally taken, cannabis products. The vast majority of Mediwiet patients have never smoked cannabis and have no history of previous recreational use.
Easton Pharmaceuticals Inc. (OTC: EAPH) recently announced it had provided BMV Medica S.A. de C.V. confirmation of final payment to BMV towards it Mexican initiatives regarding Easton's Viorra product. The company also announced a new Michigan proposal in its medical marijuana initiatives. As previously disclosed, Easton has engaged and announced that BMV Medica S.A. de C.V. has been appointed as its sole exclusive distributor in Mexico. BMV has signed an agreement with Easton on utilizing its resources and relationships aimed at marketing Viorra successfully in a market that BMV believes can be positioned as a leading-edge daily-use woman's health product to also assist in the treatment of FSAD type conditions. Easton has given BMV its approval to launch certain initiatives once manufacturing has been set up in Mexico, currently being addressed by BMV, which when complete, could also supply the United States, Canadian and International markets.
GreenGro Technologies, Inc. (OTC Pink: GRNH) recently announced a progress update on the Anaheim Location of Vertical Hydrogarden following a successful soft launch in late March, where month over month revenues have realized an increase of 367 % taking the two stores over $140,000 in April. The company announced the acquisition in Q1 of 2014 and since has focused on key strategic management hires that would propel sales of not only the Anaheim Location but the Roseville location as well. Economies of scale have since been realized with the negotiation of new manufacturing and distribution agreements from preferred partners; optimized order processing and inventory fulfillment contracts; and optimized store redesigns that increase margins and profitability of each location.
Vape Holdings, Inc. (OTCQB: VAPE) a holding company focused on providing healthy and sustainable vaporization products, recently announced that it has over $100,000 in sales of its proprietary HIVE Ceramic line since it began processing orders in early April. The Company also has back orders for over $250,000 in future sales as they await arrival of the ceramics from the Company's manufacturing facility. "I am very pleased by the early acceptance of the premium HIVE Ceramic line, especially because the majority of the purchases were made by the most informed buyers in the marketplace, those who know what is being sold nationwide," stated Kyle Tracey, CEO, Vape Holdings, Inc. "It's evident from the overwhelming response at the Cannabis Cup this past weekend that the HIVE Ceramic line, which has now expanded to 14 designs, is becoming a popular choice for consumers."
FinancialNewsMedia.com is leading provider of third party publishing & news dissemination services. If you would like more information regarding our news coverage solutions, please visit http://www.financialnewsmedia.com for more details. Get an edge on the market with our Premium News Alerts that are FREE for a limited time at http://www.financialnewsmedia.com/. Follow us on Facebook: http://www.facebook.com/financialnewsmedia and Twitter:http://twitter.com/FNMgroup.
DISCLAIMER: FN Media Group LLC (FNMG) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNMG is NOT affiliated in any manner with any company mentioned herein. FNMG and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNMG has been compensated one thousand four hundred dollars for news coverage of the current press release issued by OSL Holdings by the company.
FNMG HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.
Contact Information:
Company: FN Media Group, LLC
Contact email: [email protected]
U.S. Phone: +1-(954)-345-0611
URL: http://www.financialnewsmedia.com
SOURCE FN Media Group, LLC
Share this article